Dubai, UAE, 12 February 2026 – MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, unveiled its latest innovation, VisiOmics, a compact multiplex fluorescent staining and imaging system, at World Health Expo (“WHX”) Labs Dubai 2026, taking place from 10 to 13 February.
Showcased alongside the high-throughput T1+ sequencer and the versatile PrepAll liquid handling system, the VisiOmics platform made its official debut at Booth S1.D30, drawing strong interest from attendees and reinforcing MGI’s growing influence in translational multi-omics.
VisiOmics: Accelerating Spatial Proteomics
VisiOmics is a fully automated multiplex immunofluorescence (mIF) system designed to deliver high-resolution spatial protein expression data from tissue samples. Built to accelerate biomarker discovery and translational research, its key features include:
- Fully automated staining and imaging workflow
Powered by MGI’s proprietary FluoXpert™ mIF technology, VisiOmics integrates tissue staining and imaging into a seamless workflow, completing a 6-plex mIF process in just five hours — nearly four times faster than conventional methods — while maintaining high reproducibility. - High-throughput capability
VisiOmics supports ultra-high-throughput spatial detection and analysis of 100+ proteins on a single slide, enabling deeper insight into complex tissue environments such as the tumour immune microenvironment. - Broad compatibility
The system works with off-the-shelf antibodies and supports both FFPE and frozen tissue sections. - Actionable data output
High-accuracy spatial proteomics data for tumour classification, prognosis assessment, tumour microenvironment analysis, and broader translational research.
An Integrated Multi-Omics Ecosystem
In addition to VisiOmics, MGI showcased the T1+ sequencer and PrepAll liquid handling system at WHX Labs Dubai 2026. Together, these platforms form an integrated multi-omics portfolio designed to support diverse laboratory workflows and accelerate translational research.
T1+ Sequencer
Featuring dual flow cells and a daily output of up to 1.2 Tb, the T1+ is recognised as one of the most productive sequencers in the industry. MGI also announced two new reagent types — the FCS Kit and the STO FCL PE75 Spatiotemporal Omics Sequencing Kit — expanding compatibility with a wider range of library preparation workflows and complex sample types.
PrepAll Liquid Handling System
With eight independent channels in a compact footprint of just 0.7 m², PrepAll delivers high-precision pipetting with intuitive operation. It simplifies complex workflows while maintaining enterprise-level performance, without the cost burden of traditional automation systems.
Driving Global Research and Collaboration
MGI’s presence at WHX Labs Dubai 2026 reflects its commitment to advancing life science research across the Middle East and worldwide.
“We are excited to present technologies that elevate research accuracy and efficiency while making advanced multi-omics tools more accessible globally,” said Liu Xin, Vice President of MGI. “From accelerating spatial biology with VisiOmics to delivering high-quality sequencing data with T1+, our goal is to empower scientists with reliable, integrated and innovative tools.”
MGI invites researchers, laboratory managers, and industry professionals to explore its latest multi-omics portfolio at WHX Labs Dubai 2026. Visit Booth S1.D30 to experience these innovations first-hand.
